Evolus, Inc. (28) | Business Finance (12)
Browse by Subcategory
Recent Contracts
-
Loan Agreement, dated as of December 14, 2021, by and among Evolus, Inc. (as Borrower and a Credit Party), BioPharma Credit PLC (as Collateral Agent), BPCR Limited Partnership (as...
(Filed With SEC on December 14, 2021)
-
Registration Rights Agreement, dated February 18, 2021, by and between Evolus, Inc. and Medytox, Inc
(Filed With SEC on May 12, 2021)
-
Share Issuance Agreement, dated February 18, 2021, by and between Evolus Inc. and Medytox, Inc
(Filed With SEC on May 12, 2021)
-
Convertible Promissory Note Conversion Agreement, dated March 23, 2021, by and between Evolus, Inc. and Daewoong Pharmaceutical Co. Ltd
(Filed With SEC on May 12, 2021)
-
Underwriting Agreement, dated
(Filed With SEC on April 26, 2021)
-
Subordination Agreement. dated July 6, 2020, by and among Evolus, Inc., Oxford Finance, LLC and Daewoong Pharmaceutical Co. Ltd
(Filed With SEC on July 7, 2020)
-
Form of Convertible Promissory Note by and between Evolus, Inc. and Daewoong Pharmaceutical Co. Ltd
(Filed With SEC on July 7, 2020)
-
Convertible Promissory Note Purchase Agreement, dated July 6, 2020, by and between Evolus, Inc. and Daewoong Pharmaceutical Co. Ltd
(Filed With SEC on July 7, 2020)
-
Underwriting Agreement, dated November 6, 2019, by and between Evolus, Inc. and SVB Leerink LLC, Stifel, Nicolaus & Company, Incorporated and Cantor Fitzgerald & Co., as...
(Filed With SEC on November 12, 2019)
-
First Amendment to Loan and Security Agreement dated as of July 18, 2019, by and between the Company and Oxford Finance, LLC
(Filed With SEC on August 12, 2019)
-
Underwriting Agreement, dated as of May 15, 2019, among the Registrant, ALPHAEON Corporation and Morgan Stanley & Co. LLC
(Filed With SEC on May 21, 2019)
-
Loan and Security Agreement dated as of March 15, 2019, by and between the Company and Oxford Finance, LLC
(Filed With SEC on May 1, 2019)